ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: SA-OR016

Inhibition of Orai1-Mediated Ca2+ Signaling Ameliorates AKI-to-CKD Transition Following Ischemia and High Salt Diet

Session Information

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Authors

  • Mehrotra, Purvi, Indiana School of Medicine, Indianapolis, Indiana, United States
  • Sturek, Michael, Indiana University School of Medicine, Indianapolis, Indiana, United States
  • Basile, David P., Indiana University School of Medicine , Indianapolis, Indiana, United States
Background

Store-operated Ca2+entry (SOCE) through Orai1 channels raise intracellular Ca2+concentrations in T cells, which induce proliferation and cytokine production in immune cells. The Orai-1 gene has been linked to SCID, and loss-of-function mutation of Orai-1 in murine T cells shown to be protective in models of autoimmune disease, due to impaired production of the cytokine IL-17.

T-helper 17 (Th17) cells increase following renal injury and exposure to high-salt diet and IL-17 blockade reduces AKI-to-CKD progression. We have recently identified Orai-1 expression in AKI primed renal T cells and hypothesize that Orai1-mediated Ca2+signaling may influence Th17 differentiation and modulate CKD progression.

Methods

Rats were allowed to recover from renal ischemia for 1 week and CD4+ lymphocytes were analyzed for Ca2+and IL-17 responses in vitro. In other studies, rats were subjected to bilateral I/R and allowed to recover 24 hours with or without SOCE antagonist YM-58483 (1mg/kg). To study CKD progression, rats following unilateral ischemia were allowed to recover for 5 weeks 0.4% NaCl diet. CKD was hastened by Unx and elevated dietary NaCl (4%) for 4 weeks. In this study, rats were fed YM-58483 or vehicle daily during the high salt treatment.

Results

AKI primed CD4+ lymphocytes manifested an induction of IL-17 production in vitro to angiotensin II and 170 mMol/L Na+while ~30% of cells manifested an increase in cytosolic Ca2+; these responses were blocked by 10mM YM-58483. Rats treated with YM-58483 were protected from bilateral ischemia as indicated by lower serum creatinine (vehicle 3.3±0.4; YM-58483 2.2±0.5 mg/dl; p£0.05) and significantly reduced by ~40% Th17 infiltration. When post ischemic rats were exposed to 4% dietary salt, there was an increase in inflammatory cells and fibrosis. YM 58483 initiated during high salt feeding significantly attenuated renal CD4+, CD8+, B cells and dendritic/macrophage cells by ~50%. Th17 cells (CD4+/IL17+) were also reduced significantly (vehicle 19425±23086, YM-58483 6494±1146 cells/g; p£0.05). In addition, YM-58343 treatment also attenuated the development of interstitial fibrosis by ~86% relative to vehicle (p< 0.05).

Conclusion

Taken together, these data suggest that Orai1 activity is enhanced by renal ischemia and that Orai1-mediated Ca2+signaling increases Th17 activity and AKI-CKD progression.

Funding

  • NIDDK Support